Gline Matthew
CEO · 15 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | ROIV | Roivant Sciences Ltd. | Tax withholding | 76,171 | $35.39 | $2.7M | filing |
| 2026-04-16 | ROIV | Roivant Sciences Ltd. | Sale | 289,774 | $29.16 | $8.4M | filing |
| 2026-03-31 | ROIV | Roivant Sciences Ltd. | Tax withholding | 304,684 | $27.70 | $8.4M | filing |
| 2026-03-30 | ROIV | Roivant Sciences Ltd. | Tax withholding | 53,826 | $26.41 | $1.4M | filing |
| 2026-03-30 | ROIV | Roivant Sciences Ltd. | Option exercise | 97,319 | — | — | filing |
| 2025-12-15 | ROIV | Roivant Sciences Ltd. | J | 1,329,325 | $21.68 | $28.8M | filing |
| 2025-12-15 | ROIV | Roivant Sciences Ltd. | Option exercise | 2,272,852 | $12.68 | $28.8M | filing |
| 2025-12-15 | ROIV | Roivant Sciences Ltd. | Sale | 943,527 | $21.68 | $20.5M | filing |
| 2025-12-15 | ROIV | Roivant Sciences Ltd. | J | 797,595 | $21.68 | $17.3M | filing |
| 2025-12-15 | ROIV | Roivant Sciences Ltd. | Option exercise | 1,363,711 | $12.68 | $17.3M | filing |
| 2025-12-15 | ROIV | Roivant Sciences Ltd. | Sale | 566,116 | $21.68 | $12.3M | filing |
| 2025-12-15 | ROIV | Roivant Sciences Ltd. | Sale | 230,357 | $21.68 | $5.0M | filing |
| 2025-12-15 | ROIV | Roivant Sciences Ltd. | Option exercise | 234,096 | $4.06 | $950,429.76 | filing |
| 2025-12-15 | ROIV | Roivant Sciences Ltd. | J | 3,739 | $21.68 | $81,061.52 | filing |
| 2025-09-18 | ROIV | Roivant Sciences Ltd. | Buy | 3,315 | $15.07 | $49,957.05 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.